NARI250117P90000
- 0.00
- 0.000.00%
Inari Medical Newsroom
Analysts Offer Insights on Healthcare Companies: Cencora (COR) and Inari Medical (NARI)
A Quick Look at Today's Ratings for Inari Medical(NARI.US), With a Forecast Between $80 to $80
Wells Fargo Downgrades Inari Medical to Equal-Weight, Raises Price Target to $80
Inari Medical Analyst Ratings
Hold Rating Issued for Inari Medical Amidst Stryker Acquisition With Minimal Antitrust Concerns and Reasonable Valuation
Inari Medical Is Maintained at Neutral by Piper Sandler
A Quick Look at Today's Ratings for Inari Medical(NARI.US), With a Forecast Between $50 to $80
Deutsche Bank Downgrades Inari Medical to Hold From Buy, Raises Price Target to $80 From $68
Inari Medical Analyst Ratings
Baird Downgrades Inari Medical to Neutral, Lowers Price Target to $80
Bank of America Securities Keeps Their Buy Rating on Inari Medical (NARI)
Cautious Hold: Evaluating Inari Medical's Acquisition by Stryker Amidst Growth Deceleration and Market Uncertainties
Inari Medical Is Maintained at Hold by Truist Securities
Inari Medical Analyst Ratings
Oppenheimer Initiates Coverage On Inari Medical With Outperform Rating, Announces Price Target of $75
Truist Financial Maintains Inari Medical(NARI.US) With Hold Rating, Maintains Target Price $50
A Quick Look at Today's Ratings for Inari Medical(NARI.US), With a Forecast Between $50 to $74
Canaccord Genuity Maintains Buy on Inari Medical, Raises Price Target to $74
A Quick Look at Today's Ratings for Inari Medical(NARI.US), With a Forecast Between $48 to $86
Truist Raises Price Target on Inari Medical to $50 From $46, Keeps Hold Rating